Aquatic Capital Management LLC Halozyme Therapeutics, Inc. Transaction History

Aquatic Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$37.81 - $52.4 $828,039 - $1.15 Million	-21,900 Reduced 56.44%	16,900 $884,000
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $983,456 - $1.22 Million	29,200 Added 304.17%	38,800 $1.58 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $319,872 - $404,160	9,600 New	9,600 $355,000
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $515,902 - $874,490	15,700 New	15,700 $600,000
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $250,245 - $323,610	6,700 New	6,700 $295,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.